Palatability of a Novel Oral Formulation of Prednsione

Trial Profile

Palatability of a Novel Oral Formulation of Prednsione

Completed
Phase of Trial: Phase I

Latest Information Update: 01 Apr 2017

At a glance

  • Drugs Prednisone (Primary) ; Prednisone
  • Indications Asthma; Atopic dermatitis; Bronchitis; Cancer; Eczema; Nephrotic syndrome
  • Focus First in man; Proof of concept; Therapeutic Use
  • Most Recent Events

    • 18 Mar 2017 Results presented at the 118th Annual Meeting of the American Society for Clinical Pharmacology and Therapeutics
    • 17 Feb 2016 Status changed from not yet recruiting to completed as per ClinicalTrials.gov record.
    • 06 Jan 2015 Planned End Date changed from 1 Jan 2015 to 1 Jun 2015 as reported by ClinicalTrials.gov record.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top